Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
Clinical trial NCT05983276 · RECRUITING
Trial details
- NCT number
- NCT05983276
- Sponsor
- Loyola University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2030-08-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.